Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Cholangiocarcinoma and MET[original query] |
---|
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Human pathology 2013 Feb . Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR |
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 Jan . Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM |
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis. Przegla?d gastroenterologiczny 2015 10 (2): 108-17. Li Junshan, Han Tianjie, Xu Linlin, Luan Xiaoti |
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study. Current oncology (Toronto, Ont.) 2017 1 23 (6): e571-e575. Sheffield B S, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones S J M, Lim H J, Renouf D J, Huntsman D G, Yip S, Laskin J, Marra M, Schaeffer D |
Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology, research and practice 2020 Sep 216 (9): 153116. Pu Xiaohong, Zhu Liya, Li Feng, Zheng Jinyu, Wu Hongyan, Fu Yao, Chen Jun, Qi Lia |
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies. Frontiers in oncology 2020 5 10 536. Wang Shuhang, Chen Rongrong, Tang Yu, Yu Yue, Fang Yuan, Huang Huiyao, Wu Dawei, Fang Hong, Bai Ying, Sun Chao, Yu Anqi, Fan Qi, Gu Dejian, Yi Xin, Li Ni |
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 2023 2 14 (1): 630. Harding James J, Piha-Paul Sarina A, Shah Ronak H, Murphy Jessica J, Cleary James M, Shapiro Geoffrey I, Quinn David I, Braña Irene, Moreno Victor, Borad Mitesh, Loi Sherene, Spanggaard Iben, Park Haeseong, Ford James M, Arnedos Mónica, Stemmer Salomon M, de la Fouchardiere Christelle, Fountzilas Christos, Zhang Jie, DiPrimeo Daniel, Savin Casey, Duygu Selcuklu S, Berger Michael F, Eli Lisa D, Meric-Bernstam Funda, Jhaveri Komal, Solit David B, Abou-Alfa Ghassan |
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clinical & translational immunology 2024 1 13 (1): e1483. Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, Chen Xu, Lin Li, Baorui Liu, Jie Sh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: